Role of oxidative stress in female reproduction

Reproductive Biology and Endocrinology

Volumn 3, Issue , 2005, Pages

  Agarwal, Ashok ^a   Gupta, Sajal ^a   Sharma, Rakesh K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BIOLOGICAL MARKER; CAROTENOID; CYTOKINE; DNA; FREE RADICAL; IRON; ISOSORBIDE DINITRATE; MELATONIN; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; OXYGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RETINOL; SELENIUM; SILDENAFIL; ZINC;

ABORTION; AGE DISTRIBUTION; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; BIRTH DEFECT; CHILDBIRTH; CLINICAL TRIAL; CORPUS LUTEUM; DNA DAMAGE; DRUG EFFICACY; DRUG POTENTIATION; EMBRYO DEVELOPMENT; EMBRYO GROWTH; EMBRYOPATHY; ENDOMETRIOSIS; EPITHELIUM; FEMALE; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; FEMALE INFERTILITY; FERTILIZATION; HUMAN; HYDATIDIFORM MOLE; INFERTILITY THERAPY; INTRAUTERINE GROWTH RETARDATION; LABOR INDUCTION; LONGITUDINAL STUDY; MENSTRUAL CYCLE; OOCYTE MATURATION; OUTCOMES RESEARCH; OVARY CANCER; OVARY CYCLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; OXYGEN TISSUE LEVEL; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; REPRODUCTIVE HEALTH; REVIEW; SCAVENGING SYSTEM; SIGNAL TRANSDUCTION; SPONTANEOUS ABORTION; TISSUE DIFFERENTIATION; UTERINE CERVIX RIPENING; UTERUS CONTRACTILITY; UTERUS FUNCTION; VITAMIN SUPPLEMENTATION; AGING; ANIMAL; MENOPAUSE; PHYSIOLOGY; PREGNANCY COMPLICATION; REPRODUCTION;

AGING; ANIMALS; ANTIOXIDANTS; EMBRYONIC DEVELOPMENT; FEMALE; HUMANS; INFERTILITY, FEMALE; MENOPAUSE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PREGNANCY; PREGNANCY COMPLICATIONS; REACTIVE OXYGEN SPECIES; REPRODUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 27344456070     PISSN: 14777827     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-3-28     Document Type: Review

References (212)

1. Pierce JD, Cackler AB, Arnett MG: Why should you care about free radicals? RN 2004, 67:38-42. quiz 43
2. Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M: Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril 2003, 79:1288-1293.
3. Van Langendonckt A, Casanas-Roux F, Donnez J: Oxidative stress and peritoneal endometriosis. Fertil Steril 2002, 77:861-870.
4. Attaran M, Pasqualotto E, Falcone T, Goldberg JM, Miller KF, Agarwal A, Sharma RK: The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int J Fertil Womens Med 2000, 45:314-320.
5. Halliwell B, Gutteridge JM, Cross CE: Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992, 119:598-620.
6. Mello Filho AC, Hoffmann ME, Meneghini R: Cell killing and DNA damage by hydrogen peroxide are mediated by intracellular iron. Biochem J 1984, 218:273-275.
7. Gibson GE, Huang HM: Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases. J Bioenerg Biomembr 2004, 36:335-340.
8. Madamanchi NR, Vendrov A, Runge MS: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38.
9. Aitken RJ, Baker MA: Oxidative stress and male reproductive biology. Reprod Fertil Dev 2004, 16:581-588.
10. Evans MD, Dizdaroglu M, Cooke MS: Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 2004, 567:1-61.
11. Behrman HR, Kodaman PH, Preston SL, Gao S: Oxidative stress and the ovary. J Soc Gynecol Investig 2001, 8:S40-42.
12. Sabatini L, Wilson C, Lower A. Al-Shawaf T, Grudzinskas JG: Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization. Fertil Steril 1999, 72:1027-1034.
13. Shiotani M, Noda Y, Narimoto K, Imai K, Mori T, Fujimoto K, Ogawa K: Immunohistochemical localization of superoxide dismutase in the human ovary. Hum Reprod 1991, 6:1349-1353.
14. Suzuki T, Sugino N, Fukaya T, Sugiyama S, Uda T, Takaya R, Yajima A, Sasano H: Superoxide dismutase in normal cycling human ovaries: immunohistochemical localization and characterization. Fertil Steril 1999, 72:720-726.
15. Jozwik M, Wolczynski S, Szamatowicz M: Oxidative stress markers in preovulatory follicular fluid in humans. Mol Hum Reprod 1999, 5:409-413.
16. El Mouatassim S, Guerin P, Menezo Y: Expression of genes encoding antioxidant enzymes in human and mouse oocytes during the final stages of maturation. Mol Hum Reprod 1999, 5:720-725.
17. Guerin P, El Mouatassim S, Menezo Y: Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update 2001, 7:175-189.
18. Ishikawa M: Oxygen radicals-superoxide dismutase system and reproduction medicine. Nippon Sanka Fujinka Gakkai Zasshi 1993, 45:842-848.
19. Vega M, Johnson MC, Diaz HA, Urrutia LR, Troncoso JL, Devoto L: Regulation of human luteal steroidogenesis in vitro by nitric oxide. Endocrine 1998, 8:185-191.
20. Dong M, Shi Y, Cheng Q, Hao M: Increased nitric oxide in peritoneal fluid from women with idiopathic infertility and endometriosis. J Reprod Med 2001, 46:887-891.
21. Rosselli M, Keller PJ, Dubey RK: Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update 1998, 4:3-24.
22. Ohl J, Lefebvre-Maunoury C, Wittemer C, Nisand G, Laurent MC, Hoffmann P: Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Hum Reprod 2002, 17:2615-2620.
23. Osborn BH, Haney AF, Misukonis MA, Weinberg JB: Inducible nitric oxide synthase expression by peritoneal macrophages in endometriosis-associated infertility. Fertil Steril 2002, 77:46-51.
24. Reynaert NL, Ckless K, Wouters EF, van der Viet A, Janssen-Heininger YM: Nitric oxide and redox signaling in allergic airway inflammation. Antioxid Redox Signal 2005, 7:129-143.
25. Schulman IH, Zhou MS, Raij L: Nitric oxide, angiotensin II, and Reactive Oxygen Species in Hypertension and Atherogenesis. Curr Hypertens Rep 2005, 7:61-67.
26. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Chen JM, Tsai CH: Glutathione S-transferase MI*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis. Mol Hum Reprod 2004, 10:713-717.
27. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004, 351:159-169.
28. Ota H, Igarashi S, Hatazawa J, Tanaka T: Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril 1998, 69:303-308.
29. Lee KS, Joo BS, Na YJ, Yoon MS, Choi OH, Kim WW: Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality. J Assist Reprod Genet 2000, 17:222-228.
30. Agarwal A, Saleh RA, Bedaiwy MA: Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003, 79:829-843.
31. Chan AC: Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol 1993, 71:725-731.
32. de Matos DG, Furnus CC: The importance of having high glutathione (GSH) level after bovine in vitro maturation on embryo development effect of beta-mercaptoethanol, cysteine and cystine. Theriogenology 2000, 53:761-771.
33. Agarwal A, Allamaneni SS: Role of free radicals in female reproductive diseases and assisted reproduction. Reprod Biomed Online 2004, 9:338-347.
34. de Bruin JP, Dorland M, Spek ER, Posthuma G, van Haaften M, Looman CW, te Velde ER: Ultrastructure of the resting ovarian follicle pool in healthy young women. Biol Reprod 2002, 66:1151-1160.
35. Myatt L, Cui X: Oxidative stress in the placenta. Histochem Cell Biol 2004, 122:369-382.
36. Fainaru O, Almog B, Pinchuk I, Kupferminc MJ, Lichtenberg D, Many A: Active labour is associated with increased oxidisibility of serum lipids ex vivo. BJOG 2002, 109:938-941.
37. Mocatta TJ, Winterbourn CC, Inder TE, Darlow BA: The effect of gestational age and labour on markers of lipid and protein oxidation in cord plasma. Free Radic Res 2004, 38:185-191.
38. Wall PD, Pressman EK, Woods JR Jr: Preterm premature rupture of the membranes and antioxidants: the free radical connection. J Perinat Med 2002, 30:447-457.
39. Pressman EK, Cavanaugh JL, Mingione M, Norkus EP, Woods JR: Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study. Am J Obstet Gynecol 2003, 189:1720-1725.
40. Ray SD, Lam TS, Rotollo JA, Phadke S, Patel C, Dontabhaktuni A, Mohammad S, Lee H, Strika S, Dobrogowska A, Bruculeri C, Chou A, Patel S, Patel R, Manolas T, Stohs S: Oxidative stress is the master operator of drug and chemically-induced programmed and unprogrammed cell death: Implications of natural antioxidants in vivo. Biofactors 2004, 21:223-232.
41. Sugino N, Takiguchi S, Kashida S, Karube A, Nakamura Y, Kato H: Superoxide dismutase expression in the human corpus luteum during the menstrual cycle and in early pregnancy. Mol Hum Reprod 2000, 6:19-25.
42. Paszkowski T, Traub AI, Robinson SY, McMaster D: Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin Chim Acta 1995, 236:173-180.
43. Garcia-Pardo L, Granados MD, Gaytan F, Padilla CA, Martinez-Galisteo E, Morales C, Sanchez-Criado JE, Barcena JA: Immunolocalization of glutaredoxin in the human corpus luteum. Mol Hum Reprod 1999, 5:914-919.
44. Tranquilli AL, Bezzeccheri V, Giannubilo SR, Scagnoli C, Mazzanti L, Garzetti GG: Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004, 113:17-20.
45. Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, Ohira S, Konishi I: Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004, 444:49-55.
46. Harma M, Kocyigit A, Demir N: Role of plasma nitric oxide in complete hydatidiform mole. Eur J Gynaecol Oncol 2004, 25:333-335.
47. Harma M, Kocyigit A: Comparison of protein carbonyl and total plasma thiol concentrations in patients with complete hydatidiform mole with those in healthy pregnant women. Acta Obstet Gynecol Sound 2004, 83:857-860.
48. Harma M, Erel O: Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003, 133:563-566.
49. Loeken MR: Free radicals and birth defects. J Matern Fetal Neonatal Med 2004, 15:6-14.
50. Lagod L, Paszkowski T, Sikorski R, Rola R: The antioxidant-prooxidant balance in pregnancy complicated by spontaneous abortion. Ginekol Pol 2001, 72:1073-1078.
51. Pasqualotto EB, Agarwal A, Sharma RK, Izzo VM, Pinotti JA, Joshi NJ, Rose BI: Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil Steril 2004, 81:973-976.
52. Seino T, Saito H, Kaneko T, Takahashi T, Kawachiya S, Kurachi H: Eight-hydroxy-2′-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program. Fertil Steril 2002, 77:1184-1190.
53. Vega M, Urrutia L, Iniguez G, Gabler F, Devoto L, Johnson MC: Nitric oxide induces apoptosis in the human corpus luteum in vitro. Mol Hum Reprod 2000, 6:681-687.
54. Tsafriri A, Reich R: Molecular aspects of mammalian ovulation. Exp Clin Endocrinol Diabetes 1999, 107:1-11.
55. Van Voorhis BJ, Dunn MS, Snyder GD, Weiner CP: Nitric oxide: an autocrine regulator of human granulosa-luteal cell steroidogenesis. Endocrinology 1994, 135:1799-1806.
56. Tamate K, Sengoku K, Ishikawa M: The role of superoxide dismutase in the human ovary and fallopian tube. J Obstet Gynaecol 1995, 21:401-409.
57. Takayama K, Sasano H, Fukaya T, Morohashi K, Suzuki T, Tamura M, Costa MJ, Yajima A: Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab 1995, 80:2815-2821.
58. Sugino N, Takiguchi S, Ono M, Tamura H, Shimamura K, Nakamura Y, Tsuruta R, Sadamitsu D, Ueda T, Maekawa T, Kato H: Nitric oxide concentrations in the follicular fluid and apoptosis of granulosa cells in human follicles. Hum Reprod 1996, 11:2484-2487.
59. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ: Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000, 157:2111-2122.
60. Wang Y, Walsh SW: Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996, 3:179-184.
61. Djordjevic A, Spasic S, Jovanovic-Galovic A, Djordjevic R, Grubor-Lajsic G: Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products. J Matern Fetal Neonatal Med 2004, 16:367-372.
62. Wiktor H, Kankofer M, Schmerold I, Dadak A, Lopucki M, Niedermuller H: Oxidative DNA damage in placentas from normal and pre-eclamptic pregnancies. Virchows Arch 2004, 445:74-78.
63. Holthe MR, Staff AC, Berge LN, Lyberg T: Leukocyte adhesion molecules and reactive oxygen species in preeclampsia. Obstet Gynecol 2004, 103:913-922.
64. Ishihara O, Hayashi M, Osawa H, Kobayashi K, Takeda S, Vessby B, Basu S: Isoprostanes, prostaglandins and tocopherols in preeclampsia, normal pregnancy and non-pregnancy. Free Radic Res 2004:913-918.
65. Vaisanen-Tommiska M, Nuutila M, Ylikorkala O: Cervical nitric oxide release in women postterm. Obstet Gynecol 2004, 103:657-662.
66. Buhimschi IA, Buhimschi CS, Pupkin M, Weiner CP: Beneficial impact of term labor: nonenzymatic antioxidant reserve in the human fetus. Am J Obstet Gynecol 2003, 189:181-188.
67. ASRM: Definition of "infertility". Fertil Steril 2004, 82(Suppl 1):S206.
68. Yu SL, Yap C: Investigating the infertile couple. Ann Acad Med Singapore 2003, 32:611-613. quiz 614
69. Duckitt K: Infertility and subfertility. Clin Evid 2003:2044-2073.
70. DeCherney A, Nathan L, Eskandari M, Cadieux M: Current Obstetric & Gynecologic Diagnosis & Treatment. McGraw Hill, New York 2003, 6:979-990.
71. ASRM: Guidelines for the provision of infertility services. Fertil Steril 2004, 82(Suppl 1):S24-S25.
72. Sharma RK, Agarwal A: Role of reactive oxygen species in gynecologic diseases. Reprod Med Bio 2004, 3:177-199.
73. Dennery PA: Role of redox in fetal development and neonatal diseases. Antioxid Redox Signal 2004, 6:147-53.
74. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, Agarwal A: Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 2002, 17:426-431.
75. Bedaiwy MA, Falcone T: Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva Ginecol 2003, 55:333-345.
76. Ben-Shlomo I, Kokia E, Jackson MJ, Adashi EY, Payne DW: Interleukin-I beta stimulates nitrite production in the rat ovary: evidence for heterologous cell-cell interaction and for insulin-mediated regulation of the inducible isoform of nitric oxide synthase. Biol Reprod 1994, 51:310-318.
77. Malek A, Sager R, Schneider H: Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta 2001, 22(Suppl A):S45-50.
78. Bilodeau JF, Hubel CA: Current concepts in the use of antioxidants for the treatment of preeclampsia. J Obstet Gynaecol Can 2003, 25:742-750.
79. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ: Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004, 164:1049-1061.
80. Banerjee S, Smallwood A, Moorhead J, Chambers AE, Papageorghiou A, Campbell S, Nicolaides K: Placental expression of Interferon-gamma (IFN-gamma) and its receptor (IFN-gamma) R2 fail to switch from early hypoxic to late normotensive development in pre-eclampsia. J Clin Endocrinol Metab 2005, 90:944-952.
81. Oner-Iyidogan Y, Kocak H, Gurdol F, Korkmaz D, Buyru F: Indices of oxidative stress in eutopic and ectopic endometria of women with endometriosis. Gynecol Obstet Invest 2004, 57:214-217.
82. Sugino N, Karube-Harada A, Sakata A, Takiguchi S, Kato H: Nuclear factor-kappa B is required for tumor necrosis factor-alpha-induced manganese superoxide dismutase expression in human endometrial stromal cells. J Clin Endocrinol Metab 2002, 87:3845-3850.
83. Sugino N, Karube-Harada A, Taketani T, Sakata A, Nakamura Y: Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J Reprod Dev 2004, 50:215-225.
84. Ness RB: Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 2003, 189:280-294.
85. Murdoch WJ, Martinchick JF: Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp Biol Med (Maywood) 2004, 229:546-552.
86. Ness RB, Cottreau C: Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999, 91:1459-1467.
87. Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT: Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol 2004, 191:733-740.
88. WHO: Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol 1989, 18:538-545.
89. Young TW, Mei FC, Yang G, Thompson-Lanza JA, Liu J, Cheng X: Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry. Cancer Res 2004, 64:4577-4584.
90. Geva E, Jaffe RB: Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000, 74:429-438.
91. Zbucka M, Koda M, Tomaszewski J, Przystupa W, Sulkowski S, Wolczynski S: Angiogenesis in the female reproductive processes. Ginekol Pol 2004, 75:649-657.
92. Krussel JS, Bielfeld P, Polan ML, Simon C: Regulation of embryonic implantation. Eur J Obstet Gynecol Reprod Biol 2003, 110(Suppl I):S2-S9.
93. Sherer DM, Abulafia O: Angiogenesis during implantation, and placental and early embryonic development. Placenta 2001, 22:1-13.
94. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH: Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients. Mol Reprod Dev 2003, 66:24-31.
95. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB: Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996, 81:353-359.
96. Bausero P, Cavaille F, Meduri G, Freitas S, Perrot-Applanat M: Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis 1998, 2:167-182.
97. Albrecht ED, Babischkin JS, Lidor Y, Anderson LD, Udoff LC, Pepe GJ: Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 2003, 18:2039-2047.
98. Ushio-Fukai M, Alexander RW: Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004, 264:85-97.
99. Eyries M, Collins T, Khachigian LM: Modulation of growth factor gene expression in vascular cells by oxidative stress. Endothelium 2004, 11:133-139.
100. Sugino N, Shimamura K, Takiguchi S, Tamura H, Ono M, Nakata M, Nakamura Y, Ogino K, Uda T, Kato H: Changes in activity of superoxide dismutase in the human endometrium throughout the menstrual cycle and in early pregnancy. Hum Reprod 1996, 11:1073-1078.
101. Sugino N, Karube-Harada A, Kashida S, Takiguchi S, Kato H: Reactive oxygen species stimulate prostaglandin F2 alpha production in human endometrial stromal cells in vitro. Hum Reprod 2001, 16:1797-1801.
102. Zeller JM, Henig I, Radwanska E, Dmowski WP: Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol 1987, 13:78-82.
103. Wang Y, Sharma RK, Falcone T, Goldberg J, Agarwal A: Importance of reactive oxygen species in the peritoneal fluid of women with endometriosis or idiopathic infertility. Fertil Steril 1997, 68:826-830.
104. Murphy AA, Palinski W, Rankin S, Morales AJ, Parthasarathy S: Evidence for oxidatively modified lipid-protein complexes in endometrium and endometriosis. Fertil Steril 1998, 69:1092-1094.
105. Shanti A, Santanam N, Morales AJ, Parthasarathy S, Murphy AA: Autoantibodies to markers of oxidative stress are elevated in women with endometriosis. Fertil Steril 1999, 71:1115-1118.
106. Murphy AA, Santanam N, Morales AJ, Parthasarathy S: Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metab 1998, 83:2110-2113.
107. Foyouzi N, Berkkanoglu M, Arici A, Kwintkiewicz J, Izquierdo D, Duleba AJ: Effects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril 2004, 82(Suppl 3):1019-1022.
108. Murphy AA, Zhou MH, Malkapuram S, Santanam N, Parthasarathy S, Sidell N: RU486-induced growth inhibition of human endometrial cells. Fertil Steril 2000, 71:1014-1019.
109. Vega M, Carrasco I, Castillo T, Troncoso JL, Videla LA, Devoto L: Functional luteolysis in response to hydrogen peroxide in human luteal cells. J Endocrinol 1995, 147:177-182.
110. LaPolt PS, Leung K, Ishimaru R, Tafoya MA, You-hsin Chen J: Roles of cyclic GMP in modulating ovarian functions. Reprod Biomed Online 2003, 6:15-23.
111. Hanafy KA, Krumenacker JS, Murad F: NO, nitrotyrosine, and cyclic GMP in signal transduction. Med Sci Monit 2001, 7:801-819.
112. Ekerhovd E, Brannstrom M, Alexandersson M, Norstrom A: Evidence for nitric oxide mediation of contractile activity in isolated strips of the human Fallopian tube. Hum Reprod 1997, 12:301-305.
113. Rosselli M, Dubey RK, Rosselli MA, Macas E, Fink D, Lauper U, Keller PJ, Imthurn B: Identification of nitric oxide synthase in human and bovine oviduct. Mol Hum Reprod 1996, 2:607-612.
114. Rosselli M, Dubey RK, Imthurn B, Macas E, Keller PJ: Effects of nitric oxide on human spermatozoa: evidence that nitric oxide decreases sperm motility and induces sperm toxicity. Hum Reprod 1995, 10:1786-1790.
115. Tseng L, Zhang J, Peresleni T, Goligorsky MS: Cyclic expression of endothelial nitric oxide synthase mRNA in the epithelial glands of human endometrium. J Soc Gynecol Investig 1996, 3:33-38.
116. Taguchi M, Alfer J, Chwalisz K, Beier HM, Classen-Linke I: Endothelial nitric oxide synthase is differently expressed in human endometrial vessels during the menstrual cycle. Mol Hum Reprod 2000, 6:185-190.
117. Telfer JF, Lyall F, Norman JE, Cameron IT: Identification of nitric oxide synthase in human uterus. Hum Reprod 1995, 10:19-23.
118. Norman JE, Thompson AJ, Telfer JF, Young A, Greer IA, Cameron IT: Myometrial constitutive nitric oxide synthase expression is increased during human pregnancy. Mol Hum Reprod 1999, 5:175-181.
119. Sun X, Qiu X, Gemzell-Danielsson K: Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase. Fertil Steril 2003, 80:1454-60.
120. Shaamash AH, Zakhari MM: Increased serum levels of nitric oxide metabolites among users: a possible role in progestin-induced bleeding. Hum Reprod 2005, 20:302-306.
121. Bansal RK, Goldsmith PC, He Y, Zaloudek CJ, Ecker JL, Riemer RK: A decline in myometrial nitric oxide synthase expression is associated with labor and delivery. J Clin Invest 1997, 99:2502-2508.
122. Seyffarth G, Nelson PN, Dunmore SJ, Rodrigo N, Murphy DJ, Carson RJ: Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture. Reprod Biol Endocrinol 2004, 2:29.
123. Marinoni E, Di Iorio R, Villaccio B, Alberini A, Rota F, Cosmi EV: Amniotic fluid nitric oxide metabolite levels and nitric oxide synthase localization in feto-placental tissues are modified in association with human labor. Eur J Obstet Gynecol Reprod Biol 2000, 89:47-54.
124. Lee TH, Wu MY, Chen MJ, Chao KH, Ho HN, Yang YS: Nitric oxide is associated with poor embryo quality and pregnancy outcome in in vitro fertilization cycles. Fertil Steril 2004, 82:126-131.
125. Oztezcan S, Turkoglu UM, Kervancioglu E, Kocak T, Kocak-Toker N, Aykac-Toker G: In vitro effects of peroxynitrite on human spermatozoa. Andrologia 1999, 31:195-198.
126. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM: Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001, 282:1075-1079.
127. Polak G, Koziol-Montewka M, Gogacz M, Blaszkowska I, Kotarski J: Total antioxidant status of peritoneal fluid in infertile women. Eur J Obstet Gynecol Reprod Biol 2001, 94:261-263.
128. Arumugam K, Dip YC: Endometriosis and infertility: the role of exogenous lipid peroxides in the peritoneal fluid. Fertil Steril 1995, 63:198-199.
129. Ho HN, Wu MY, Chen SU, Chao KH, Chen CD, Yang YS: Total antioxidant status and nitric oxide do not increase in peritoneal fluids from women with endometriosis. Hum Reprod 1997, 12:2810-2815.
130. Khorram O, Lessey BA: Alterations in expression of endometrial endothelial nitric oxide synthase and alpha(v)beta(3) integrin in women with endometriosis. Fertil Steril 2002, 78:860-864.
131. Wu MY, Chao KH, Yang JH, Lee TH, Yang YS, Ho HN: Nitric oxide synthesis is increased in the endometrial tissue of women with endometriosis. Hum Reprod 2003, 18:2668-2671.
132. Kamada Y, Nakatsuka M, Asagiri K, Noguchi S, Habara T, Takata M, Kudo T: GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis. Hum Reprod 2000, 15:2512-2519.
133. Ekerhovd E, Enskog A, Caidahl K, Klintland N, Nilsson L, Brannstrom M, Norstrom A: Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome. Hum Reprod 2001, 16:1334-1339.
134. Portz DM, Elkins TE, White R, Warren J, Adadevoh S, Randolph J: Oxygen free radicals and pelvic adhesion formation: I. Blocking oxygen free radical toxicity to prevent adhesion formation in an endometriosis model. Int J Fertil 1991, 36:39-42.
135. Zervou S, Karteris E, Goumenou AG, Vatish M, Koumantakis EE, Hillhouse EW: The Glu298-->Asp polymorphism of the endothelial nitric oxide synthase gene is associated with endometriosis. Fertil Steril 2003, 80:1524-1525.
136. Ota H, Igarashi S, Hatazawa J, Tanaka T: Endometriosis and free radicals. Gynecol Obstet Invest 1999, 48(Suppl 1):29-35.
137. Leyendecker G, Kunz G, Wildt L, Beil D, Deininger H: Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 1996, 11:1542-1551.
138. Kim KH, Oh DS, Jeong JH, Shin BS, Joo BS, Lee KS: Follicular blood flow is a better predictor of the outcome of in vitro fertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations. Fertil Steril 2004, 82:586-592.
139. Song IO, Huh Y, Yoo KJ, Choi BC, Paik EC, Son IP: Increased expression of endothelial nitric oxide synthase in endometrium of infertile women with endometriosis or hydrosalpinx during the window of implantation. Abstract of the 15th Annual Meeting of the ESHRE. Tours, France. June 14-17, 2000, Abstract No. O-035
140. Cicinelli E, Ignarro LJ, Lograno M, Galantino P, Balzano G, Schonauer LM: Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle. Fertil Steril 1996:1036-1038.
141. Friden BE, Runesson E, Hahlin M, Brannstrom M: Evidence for nitric oxide acting as a luteolytic factor in the human corpus luteum. Mol Hum Reprod 2000, 6:397-403.
142. Anteby EY, Hurwitz A, Korach O, Revel A, Simon A, Finci-Yeheskel Z, Mayer M, Laufer N: Human follicular nitric oxide pathway: relationship to follicular size, oestradiol concentrations and ovarian blood flow. Hum Reprod 1996, 11:1947-1951.
143. Manau D, Balasch J, Jimenez W, Fabregues F, Casamitjana R, Creus M, Arroyo V, Vanrell JA: Adrenomedullin and nitric oxide in menstrual and in vitro fertilization cycles. Relationship to estradiol. Acta Obstet Gynecol Scand 1999, 78:626-631.
144. Fabregues F, Balasch J, Manau D, Creus M, Jimenez W, Carmona F, Casamit J, Vanrell JA: Circulating levels of nitric oxide in successful and unsuccessful implantation after in vitro fertilization and embryo transfer. Relationship to estradiol and progesterone. Acta Obstet Gynecol Scand 2000, 79:564-569.
145. Manau D, Balasch J, Jimenez W, Fabregues F, Civico S, Casamitjana R, Creus M, Vanrell JA: Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response. Hum Reprod 2000, 15:1295-1299.
146. Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A: Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod 1999, 14:1690-1697.
147. Battaglia C, Regnani G, Marsella T, Facchinetti F, Volpe A, Venturoli S, Flamigni C: Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. Hum Reprod 2002, 17:659-665.
148. Barrionuevo MJ, Schwandt RA, Rao PS, Graham LB, Maisel LP, Yeko TR: Nitric oxide (NO) and interleukin-1 beta (IL-1 beta) in follicular fluid and their correlation with fertilization and embryo cleavage. Am J Reprod Immunol 2000, 44:359-364.
149. Hata T, Hashimoto M, Manabe A, Aoki S, Iida K, Masumura S, Miyazaki K: Maternal and fetal nitric oxide synthesis is decreased in pregnancies with small for gestational age infants. Hum Reprod 1998, 13:1070-1073.
150. Lees C, Campbell S, Jauniaux E. Brown R, Ramsay B, Gibb D, Moncada S, Martin JF: Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 1994, 343:1325-1326.
151. Braude P, Rowell P: Assisted conception. II - in vitro fertilisation and intracytoplasmic sperm injection. BMJ 2003, 327:852-855.
152. Isaksson R, Tiitinen A: Present concept of unexplained infertility. Gynecol Endocrinol 2004, 18:278-290.
153. Bedaiwy MA, Falcone T, Mohamed MS, Aleem AA, Sharma RK, Worley SE, Thornton J, Agarwal A: Differential growth of human embryos in vitro: role of reactive oxygen species. Fertil Steril 2004, 82:593-600.
154. Oyawoye O, Abdel Gadir A, Garner A, Constantinovici N, Perrett C, Hardiman P: Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. Hum Reprod 2003, 18:2270-2274.
155. Paszkowski T, Clarke RN, Hornstein MD: Smoking induces oxidative stress inside the Graafian follicle. Hum Reprod 2002, 17:921-925.
156. Van Blerkom J, Antczak M, Schrader R: The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997, 12:1047-1055.
157. Yang HW, Hwang KJ, Kwon HC, Kim HS, Choi KW, Oh KS: Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod 1998, 13:998-1002.
158. Kurzawa R, Glabowski W, Baczkowski T, Wiszniewska B, Marchlewicz M: Growth factors protect in vitro cultured embryos from the consequences of oxidative stress. Zygote 2004, 12:231-240.
159. Reubinoff BE, Har-El R, Kitrossky N, Friedler S, Levi R, Lewin A, Chevion M: Increased levels of redox-active iron in follicular fluid: a possible cause of free radical-mediated infertility in beta-thalassemia major. Am J Obstet Gynecol 1996, 174:914-918.
160. Wiener-Megnazi Z, Vardi L, Lissak A, Shnizer S, Zeev Reznick A, Ishai D, Lahav-Baratz S, Shiloh H, Koifman M, Dirnfeld M: Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate with outcome parameters in in vitro fertilization. Fertil Steril 2004, 82(Suppl 3):1171-1176.
161. Torok A, Nemeth P, Torok B, Berki T, Tinneberg HR, Bodis J: Organic hydroperoxide-induced chemiluminescence of follicular fluid and blood serum samples obtained from women pretreated for in vitro fertilization. Gynecol Obstet Invest 2004, 57:72-79.
162. Shiverick KT, Salafia C: Cigarette smoking and pregnancy I: ovarian, uterine and placental effects. Placenta 1999, 20:265-272.
163. Schweigert FJ, Steinhagen B, Raila J, Siemann A, Peet D, Buscher U: Concentrations of carotenoids, retinol and alpha-tocopherol in plasma and follicular fluid of women undergoing IVF. Hum Reprod 2003, 18:1259-1264.
164. Takasaki A, Nakamura Y, Tamura H, Shimamura K, Morioka H: Melatonin as a new drug for improving oocyte quality. Reprod Med Biol 2003, 2:139-144.
165. Harvey AJ, Kind KL, Thompson JG: REDOX regulation of early embryo development. Reproduction 2002, 123:479-486.
166. Knott L, Hartridge T, Brown NL, Mansell JP, Sandy JR: Homocysteine oxidation and apoptosis: a potential cause of cleft palate. In Vitro Cell Dev Biol Anim 2003, 39:98-105.
167. Parman T, Wiley MJ, Wells PG: Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 1999, 5:582-585.
168. Burton GJ, Hempstock J, Jauniaux E: Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online 2003, 6:84-96.
169. Wentzel P, Welsh N, Eriksson UJ: Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 1999, 48:813-820.
170. Nicol CJ, Zielenski J, Tsui LC, Wells PG: An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis. Faseb J 2000, 14:111-127.
171. Dumoulin JC, Meijers CJ, Bras M, Coonen E, Geraedts JP, Evers JL: Effect of oxygen concentration on human in-vitro fertilization and embryo culture. Hum Reprod 1999, 14:465-469.
172. Kitagawa Y, Suzuki K, Yoneda A, Watanabe T: Effects of oxygen concentration and antioxidants on the in vitro developmental ability, production of reactive oxygen species (ROS), and DNA fragmentation in porcine embryos. Theriogenology 2004, 62:1186-1197.
173. Paszkowski T, Clarke RN: Antioxidative capacity of preimplantation embryo culture medium declines following the incubation of poor quality embryos. Hum Reprod 1996, 11:2493-2495.
174. Ermilov A, Diamond MP, Sacco AG, Dozortsev DD: Culture media and their components differ in their ability to scavenge reactive oxygen species in the plasmid relaxation assay. Fertil Steril 1999, 72:154-157.
175. Agarwal A, Nallella KP, Allamaneni SS, Said TM: Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online 2004, 8:616-627.
176. Henmi H, Endo T, Kitajima Y, Manase K, Hata H, Kudo R: Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril 2003, 80:459-461.
177. Vural P, Akgul C, Yildirim A, Canbaz M: Antioxidant defence in recurrent abortion. Clin Chim Acta 2000, 295:169-177.
178. Crha I, Hruba D, Ventruba P, Fiala J, Totusek J, Visnova H: Ascorbic acid and infertility treatment. Cent Eur J Public Health 2003, 11:63-67.
179. Westphal LM, Polan ML, Trant AS, Mooney SB: A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med 2004, 49:289-293.
180. Griesinger G, Franke K, Kinast C, Kutzelnigg A, Riedinger S, Kulin S, Kaali SG, Feichtinger W: Ascorbic acid supplement during luteal phase in IVF. J Assist Reprod Genet 2002, 19:164-168.
181. Catt JW, Henman M: Toxic effects of oxygen on human embryo development. Hum Reprod 2000, 15(Suppl 2):199-206.
182. Lane M, Maybach JM, Gardner DK: Addition of ascorbate during cryopreservation stimulates subsequent embryo development. Hum Reprod 2002, 17:2686-2693.
183. Chui DK, Pugh ND, Walker SM, Gregory L, Shaw RW: Follicular vascularity - the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study. Hum Reprod 1997, 12:191-196.
184. Sher G, Fisch JD: Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 2000, 15:806-809.
185. Sher G, Fisch JD: Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 2002, 78:1073-1076.
186. Lornage J: Biological aspects of endometriosis in vitro fertilization. J Gynecol Obstet Biol Reprod (Paris) 2003, 32:S48-50.
187. Tarin JJ: Potential effects of age-associated oxidative stress on mammalian oocytes/embryos. Mol Hum Reprod 1996, 2:717-724.
188. Tarin JJ, Perez-Albala S, Cano A: Consequences on offspring of abnormal function in ageing gametes. Hum Reprod Update 2000, 6:532-549.
189. Arteaga E, Villaseca P, Rojas A, Arteaga A, Bianchi M: Comparison of the antioxidant effect of estriol and estradiol on low density lipoproteins in post-menopausal women. Rey Med Chil 1998, 126:481-487.
190. Tamir S, Izrael S, Vaya J: The effect of oxidative stress on ERalpha and ERbeta expression. J Steroid Biochem Mol Biol 2002, 81:327-232.
191. Villar J, Say L, Shennan A, Lindheimer M, Duley L, Conde-Agudelo A, Merialdi M: Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of preeclampsia and eclampsia. Int J Gynaecol Obstet 2004, 85(Suppl 1):S28-S41.
192. Harma M, Erel O: Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 2005, 118:47-51.
193. Aydin S, Benian A, Madazli R, Uludag S, Uzun H, Kaya S: Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004, 113:21-25.
194. Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J, Romney SL: Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol 1994, 171:150-157.
195. Pijnenborg R, Dixon G, Robertson WB, Brosens I: Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980, 1:3-19.
196. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L: Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999, 354:810-816.
197. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM: Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 1997, 104:689-696.
198. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM: Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 2005, 192:520-521.
199. Jauniaux E, Hempstock J, Greenwold N, Burton GJ: Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003, 162:115-125.
200. Jauniaux E, Cindrova-Davies T, Johns J, Dunster C, Hempstock J, Kelly FJ, Burton GJ: Distribution and transfer pathways of antioxidant molecules inside the first trimester human gestational sac. J Clin Endocrinol Metab 2004, 89:1452-1458.
201. Miller H, Wilson R, Jenkins C, MacLean MA, Roberts J, Walker JJ: Glutathione levels and miscarriage. Fertil Steril 2000, 74:1257-1258.
202. Sata F, Yamada H, Kondo T, Gong Y, Tozaki S, Kobashi G, Kato EH, Fujimoto S, Kishi R: Glutathione S-transferase MI and TI polymorphisms and the risk of recurrent pregnancy loss. Mol Hum Reprod 2003, 9:165-169.
203. Cramer DW, Wise LA: The epidemiology of recurrent pregnancy loss. Semin Reprod Med 2000, 18:331-339.
204. Comporti M, Signorini C, Leoncini S, Buonocore G, Rossi V, Ciccoli L: Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 2004, 37:724-732.
205. Ekerhovd E, Weijdegard B, Brannstrom M, Mattsby-Baltzer I, Norstrom A: Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2). Am J Obstet Gynecol 2002, 186:745-750.
206. Plessinger MA, Woods JR Jr, Miller RK: Pretreatment of human amnion-chorion with vitamins C and E prevents hypochlorous acid-induced damage. Am J Obstet Gynecol 2000, 183:979-985.
207. Siega-Riz AM, Promislow JH, Savitz DA, Thorp JM Jr, McDonald T: Vitamin C intake and the risk of preterm delivery. Am J Obstet Gynecol 2003, 189:519-525.
208. Holmes VA, Young IS, Maresh MJ, Pearson DW, Walker JD, McCance DR: The Diabetes and Pre-eclampsia Intervention Trial. Int J Gynaecol Obstet 2004, 87:66-71.
209. Mayne ST, Wright ME, Cartmel B: Assessment of antioxidant nutrient intake and status for epidemiologic research. J Nutr 2004, 134:3199S-3200S.
210. Kupka R, Msamanga GI, Spiegelman D, Morris S, Mugusi F, Hunter DJ, Fawzi WW: Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women in Tanzania. J Nutr 2004, 134:2556-2560.
211. Fawzi W, Msamanga G: Micronutrients and adverse pregnancy outcomes in the context of HIV infection. Nutr Rey 2004, 62:269-275.
212. Mates M: Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000, 153:83-104.